Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer

Carlos A. Castaneda, Henry L. Gómez

Research output: Contribution to journalArticle

Abstract

Resistance to chemotherapy is a complex and very frequent problem in the treatment of breast cancer. It is associated with a poor prognosis and short overall survival. We report a patient with advanced breast cancer without response to anthracyclines or taxanes but who controlled the disease for 15 months with the combination of ixabepilone and capecitabine.
Original languageAmerican English
JournalClinical Breast Cancer
DOIs
StatePublished - 1 Jan 2009
Externally publishedYes

Fingerprint Dive into the research topics of 'Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer'. Together they form a unique fingerprint.

  • Cite this